Evidence map›Paper›PMID 34230210›Full record

ArticleScience signaling2021

Kynurenic acid may underlie sex-specific immune responses to COVID-19.

Yuping Cai, Daniel J Kim, Takehiro Takahashi, David I Broadhurst, Hong Yan, Shuangge Ma, Nicholas J W Rattray, Arnau Casanovas-Massana, Benjamin Israelow, Jon Klein and 12 more

Open access · hybridAbstract read
In one paragraph

Article in Science signaling, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The peptidoglycan ofScience translational medicine · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 4 countries.

Yuping CaiDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT 06510, USA.ORCID 0000-0002-5701-3609
Daniel J KimDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Takehiro TakahashiDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.ORCID 0000-0002-1061-356X
David I BroadhurstCentre for Integrative Metabolomics and Computational Biology, School of Science, Edith Cowan University, Joondalup 6027, Australia.
Hong YanDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT 06510, USA.
Shuangge MaDepartment of Biostatistics, Yale School of Public Health, New Haven, CT 06510, USA.ORCID 0000-0001-9001-4999
Nicholas J W RattrayStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Arnau Casanovas-MassanaDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.ORCID 0000-0002-3301-6143
Benjamin IsraelowDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.ORCID 0000-0002-1308-8246
Jon KleinDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.ORCID 0000-0002-3552-7684
Carolina LucasDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Tianyang MaoDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.ORCID 0000-0001-9251-8592
Adam J MooreDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.
M Catherine MuenkerDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.
Ji Eun OhDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Julio SilvaDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Patrick WongDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.ORCID 0000-0002-1169-6395
Yale IMPACT Research team
Albert I KoDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.
Sajid A KhanDepartment of Surgery, Division of Surgical Oncology, Yale University School of Medicine, New Haven, CT 06520, USA.
Akiko IwasakiDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.ORCID 0000-0002-7824-9856
Caroline H JohnsonDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT 06510, USA. caroline.johnson@yale.edu.ORCID 0000-0002-5298-1299
Yale University · USChinese Academy of Sciences · CNEdith Cowan University · AUHoward Hughes Medical Institute · USUniversity of Strathclyde · GB

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Systems investigation of vaccine responses in B cell depleted autoimmune patientsU19AI089992 · NIAID · YALE UNIVERSITY · PI David A. Hafler, RUTH R MONTGOMERY · 2010 to 2026
$50.4M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Medical Scientist Training ProgramT32GM136651 · NIGMS · YALE UNIVERSITY · PI BARBARA I KAZMIERCZAK · 2020 to 2026
$16.5M
TRAINING IN THE PATHOGENESIS OF INFECTIOUS DISEASEST32AI007517 · NIAID · YALE UNIVERSITY · PI Jaimie Meyer, Albert C Shaw · 1997 to 2026
$6.1M
Exploring the Innate Sensors Underlying Cancer ImmunosurveillanceF30CA236466 · NCI · YALE UNIVERSITY · PI KIM, DANIEL J · 2019 to 2021
$111k
BLRD VA I01 BX004661NCATS NIH HHS UL1 TR001863NCI NIH HHS F30 CA236466NIAID NIH HHS T32 AI007517NIAID NIH HHS U19 AI089992NIGMS NIH HHS T32 GM007205NIGMS NIH HHS T32 GM136651NIH HHS U19 AI08992
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) has poorer clinical outcomes in males than in females, and immune responses underlie these sex-related differences. Because immune responses are, in part, regulated by metabolites, we examined the serum metabolomes of COVID-19 patients. In male patients, kynurenic acid (KA) and a high KA-to-kynurenine (K) ratio (KA:K) positively correlated with age and with inflammatory cytokines and chemokines and negatively correlated with T cell responses. Males that clinically deteriorated had a higher KA:K than those that stabilized. KA inhibits glutamate release, and glutamate abundance was lower in patients that clinically deteriorated and correlated with immune responses. Analysis of data from the Genotype-Tissue Expression (GTEx) project revealed that the expression of the gene encoding the enzyme that produces KA, kynurenine aminotransferase, correlated with cytokine abundance and activation of immune responses in older males. This study reveals that KA has a sex-specific link to immune responses and clinical outcomes in COVID-19, suggesting a positive feedback between metabolites and immune responses in males.

Indexed as

SARS-CoV-2AdultAgedCase-Control StudiesCOVID-19Cytokine Release SyndromeCytokinesFemaleHumansKynurenic AcidLogistic ModelsMaleMetabolic Networks and PathwaysMetabolomicsMiddle AgedMultivariate AnalysisCytokinesKynurenic AcidTryptophan

Identifiers

PMID34230210
PMCPMC8432948
OpenAlexW3182447987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.